US and Europe Surrogacy Market to Grow at a CAGR of 19.4% to reach US$ 25,284.02 million from 2022 to 2030
The US and Europe surrogacy market size is expected to grow from US$ 6,113.72 million in 2022 to US$ 25,284.02 million in 2030; it is estimated to record a CAGR of 19.4% from 2022 to 2030.
Analyst Perspective:
Factors affecting the growth of the surrogacy market may vary across different regions and countries. The establishment of clear and favorable legal frameworks for surrogacy can encourage the growth of the US and Europe surrogacy market. In some cases, individuals or couples may turn to surrogacy due to limited adoption services or long waiting periods associated with the adoption process. Surrogacy can provide an alternative pathway to parenthood for those who are unable to adopt or prefer a genetic connection to the child. As societies become more receptive to non-traditional family structures, there has been a shift in the perspective of surrogacy. Greater awareness and understanding of the options available for family building, including surrogacy, have contributed to the growth of the US and Europe surrogacy market.
Market Overview:
The US and Europe surrogacy market is a complex and multifaceted marketplace that involves individuals or couples, often referred to as intended parents, seeking the assistance of a surrogate mother to carry and deliver a child on their behalf. While regulations and practices vary across countries. Surrogacy can take place within a country’s borders or involve intended parents from one country seeking surrogacy services in another country. International surrogacy often occurs when individuals or couples face legal restrictions or seek more favorable conditions abroad. Surrogacy agencies and fertility clinics play a significant role in facilitating surrogacy arrangements in the US and Europe surrogacy market. These organizations help match intended parents with surrogates, coordinate medical procedures, and navigate the legal and logistic aspects of the process. Surrogacy raises various ethical, legal, and social considerations, including the rights and well-being of the surrogate’s mother, the legal parentage of the child, the potential exploitation of surrogates, and the best interests of the child. Different countries and jurisdictions approach these issues differently.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US and Europe Surrogacy Market: Strategic Insights
Market Size Value in US$ 6,113.72 million in 2022 Market Size Value by US$ 25,284.02 million in 2030 Growth rate CAGR of 19.4% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
US and Europe Surrogacy Market: Strategic Insights
| Market Size Value in | US$ 6,113.72 million in 2022 |
| Market Size Value by | US$ 25,284.02 million in 2030 |
| Growth rate | CAGR of 19.4% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Technological Advancements in Reproductive Technologies to Drive US and Europe Surrogacy Market Growth
Infertility can be treated using assisted reproductive technologies (ART), which use techniques such as in-vitro fertilization, artificial insemination, and surrogacy. These advancements have revolutionized the field of ART, providing new possibilities for individuals and couples facing fertility challenges. Due to its higher success rate, in-vitro fertilization (IVF) is projected to become the most popular method of treating infertility. As the success rates of IVF continue to rise, more individuals and couples may turn to surrogacy as an option when other fertility treatments have been unsuccessful.
Another technological advancement that would contribute to the US and Europe surrogacy market growth is preimplantation genetic testing (PGT). The PGT allows for the screening of embryos for genetic defects before transfer to the surrogate mother's uterus. This technology allows intended parents to select embryos with a higher likelihood of successful implantation and lowers the risk of genetic disorders in offspring. As PGT becomes more sophisticated and accessible, it may further drive the demand for surrogacy to achieve a healthy pregnancy. In addition, developments in gestational carrier screening provide a more comprehensive assessment of surrogate mothers' health and potential risks during pregnancy. These technologies allow for a thorough evaluation of the surrogate's suitability, increasing the confidence of intended parents. Thus, the factors mentioned above are expected to boost the US and Europe surrogacy market during the forecast period.
Segmental Analysis:
Based on technology, the US and Europe surrogacy market is categorized into intrauterine insemination (IUI) and in-vitro fertilization (IVF). In 2022, the IVF segment held a larger share of the US and Europe surrogacy market. Moreover, it is expected to register a higher CAGR in the market during 2022–2030. IVF has a higher success rate than IUI, as the embryo is directly transferred to the uterus. In the case of IVF technology, genetic testing of the embryo can be done, which can help identify genetic disorders before implantation. Moreover, embryos can be frozen after fertilization if the intended parents want delayed conception; frozen embryos can also be used upon the failure of previous IVF cycles. IVF can be performed via two techniques: classical/standard IVF and intracytoplasmic sperm injection (ICSI). In February 2023, Bumrungrad launched its fertility center and IVF clinic to deliver holistic reproductive care, from consultation to assisted reproductive technology to the clients. In October 2022, TMRW Life Sciences, Inc. launched the world's most advanced cryo-storage facility for fertility specimens. This technology-enabled facility, located in New York, delivers a new standard of care directly to patients for the first time and to fertility clinic partners providing unprecedented levels of transparency of frozen eggs and embryos at the heart of almost every IVF journey.
Regional Analysis:
The US surrogacy market was valued at US$ 4,207.37 million in 2022 and is projected to reach US$ 17,265.05 million by 2030; it is expected to grow at a CAGR of 19.3% during the forecast period. The US held the largest share of the US and Europe surrogacy market in 2022. The market growth in this country is attributed to the increasing cases of infertility, an emerging trend of late pregnancies, and a rise in the rate of gamete donations. The availability of fertility treatments, increased awareness about infertility, an upsurge in disposable income, and the enactment of favorable reimbursement policies further drive the surrogacy market growth in the US. Stringent surrogacy legislation due to the "Baby M" case in 1986 prompted many surrogacy service providers to adopt gestational practices to avoid legal penalties. However, as the demand remained steady, these laws had little impact on the growth of the surrogacy industry. The subsequent expansion of fertility and surrogacy clinics, and a rise in same-sex marriages are anticipated to create attractive growth possibilities for the US and Europe surrogacy market.
Financial aspects also play a role in the growth of the US surrogacy market. While the costs associated with surrogacy can vary significantly, clinics in the US offer a range of options catering to different budget scenarios. According to American Fertility Services (AFS), surrogacy costs in the US range from US$ 60,000 to US$ 150,000; the total costs may vary in every case. Further, the availability of insurance coverage for surrogacy-related medical expenses and competitive pricing structures benefits the surrogacy industry in the US.
Key Player Analysis:
The US and Europe surrogacy market analysis is based on the performance profiles of London Women's Clinic, The Centre for Reproductive and Genetic Health, Global Surrogacy, Miracle Baby Surrogacy, Lotus Surrogacy, VittoriaVita, Circle Surrogacy and Egg Donation, Redia IVF, New Life Ukraine, and Sensible Surrogacy, among others.
Recent Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the US and Europe surrogacy market. A few recent key market developments in the US and Europe surrogacy market are listed below:
- In March 2023, Ovation Fertility and US Fertility signed a definitive agreement, and they completed a successful federal regulatory evaluation process post that, creating the leading fertility platform in the US. Together, these companies provide advanced fertility care through 28 laboratories established in more than 90 locations.
- In April 2023, acquired two fertility clinics in Bromley and Eastbourne and a satellite centre at Brighton. London Women’s Clinic offers its world-leading services in reproductive medicine across the entire South-East region.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Technology, Age Group, and Service Order
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Key factors driving the market growth are the increasing number of infertility cases and growing awareness of treatment of infertility.
US and Europe Surrogacy market, based on technology, is segmented into intrauterine insemination (IUI) and in-vitro fertilization (IVF). In 2022, the in-vitro fertilization (IVF) segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming years.
US and Europe Surrogacy market is segmented by region into Europe, and the Middle East & Africa. US is likely to continue its dominance in the US and Europe Surrogacy market during 2022–2028. The US holds the largest share of the market and is expected to continue this trend during the forecast period.
The US and Europe Surrogacy market, based on end user, is segmented hospitals, fertility clinics, and others. In 2022, the fertility clinics segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming years.
Companies operating in the market are London Women's Clinic, The Centre for Reproductive and Genetic Health, Global Surrogacy, Miracle Baby Surrogacy, Lotus Surrogacy, VittoriaVita, Circle Surrogacy and Egg Donation, Redia IVF, New Life Ukraine, and Sensible Surrogacy.
Surrogacy is a practice where a woman carries a pregnancy and gives birth to a child on behalf of another individual or couple, commonly referred to as intended parents. When a couple doesn't want to bear the pregnancy themselves, when pregnancy is physically impossible, when pregnancy risks are risky for the intended mother, or when a single man or a male couple wants to have a kid, people may investigate surrogacy arrangements.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US and Europe Surrogacy market – by Type
1.3.2 US and Europe Surrogacy market – by Technology
1.3.3 US and Europe Surrogacy market – by Age Group
1.3.4 US and Europe Surrogacy market – by Service Provider
1.3.5 US and Europe Surrogacy market – by Country
2. US and Europe Surrogacy market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US and Europe Surrogacy market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US – PEST Analysis
4.2.2 Europe – PEST Analysis
5. US and Europe Surrogacy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Infertility Cases
5.1.2 Growing Awareness of Treatment of Infertility
5.2 Market Restraints
5.2.1 High Cost Involved in Procedure
5.3 Market Opportunities
5.3.1 Technological Advancements in Reproductive Technologies
5.4 Future Trends
5.4.1 Commercialization of Surrogacy
5.5 Impact Analysis
6. US and Europe Surrogacy market Analysis
6.1 US and Europe Surrogacy market Revenue Forecast and Analysis
6.2 Cost Analysis
6.3 Regulatory Scenario
6.3.1 United States
6.3.2 Italy
6.3.3 UK
6.3.4 Denmark
6.3.5 The Netherlands
6.3.6 Ireland
7. US and Europe Surrogacy Market Analysis – by Type
7.1 Overview
7.2 Gestational Surrogacy
7.2.1 Overview
7.2.2 Gestational Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Traditional Surrogacy
7.3.1 Overview
7.3.2 Traditional Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
8. US and Europe Surrogacy Market Analysis – by Technology
8.1 Overview
8.2 Intrauterine Insemination (IUI)
8.2.1 Overview
8.2.2 Intrauterine Insemination (IUI): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
8.3 In-Vitro Fertilization (IVF)
8.3.1 Overview
8.3.2 In-Vitro Fertilization (IVF): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3 Classical/Standard IVF
8.3.3.1 Overview
8.3.3.2 Classical/Standard IVF: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4 Intracytoplasmic Sperm Injection (ICSI)
8.3.4.1 Overview
8.3.4.2 Intracytoplasmic Sperm Injection (ICSI): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9. US and Europe Surrogacy Market Analysis – by Age Group
9.1 Overview
9.2 Below 35 Years
9.2.1 Below 35 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.3-37 Years
9.3.1-37 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.4-39 Years
9.4.1-39 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.5-42 Years
9.5.1-42 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.6-44 Years
9.6.1-44 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Over 44 Years
9.7.1 Over 44 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
10. US and Europe Surrogacy Market Analysis – by Service Order
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Fertility Clinics
10.3.1 Overview
10.3.2 Fertility Clinics: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
11. US and Europe Surrogacy Market – Regional Analysis
11.1 Europe
11.1.1 Overview
11.1.2 Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.3 Europe Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.4 Europe Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.4.1 Europe Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.5 Europe Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.6 Europe Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7 Europe Surrogacy Market, by Country
11.1.7.1 Italy
11.1.7.1.1 Overview
11.1.7.1.2 Italy Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.1.3 Italy Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.1.4 Italy Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.1.4.1 Italy Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.1.5 Italy Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.1.6 Italy Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7.2 UK
11.1.7.2.1 Overview
11.1.7.2.2 UK Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.2.3 UK Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.2.4 UK Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.2.4.1 UK Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.2.5 UK Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.2.6 UK Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7.3 Denmark
11.1.7.3.1 Overview
11.1.7.3.2 Denmark Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.3.3 Denmark Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.3.4 Denmark Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.3.4.1 Denmark Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.3.5 Denmark Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.3.6 Denmark Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7.4 The Netherlands
11.1.7.4.1 Overview
11.1.7.4.2 The Netherlands Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.4.3 The Netherlands Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.4.4 The Netherlands Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.4.4.1 The Netherlands Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.4.5 The Netherlands Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.4.6 The Netherlands Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7.5 Ireland
11.1.7.5.1 Overview
11.1.7.5.2 Ireland Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.5.3 Ireland Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.5.4 Ireland Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.5.4.1 Ireland Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.5.5 Ireland Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.5.6 Ireland Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.1.7.6 Rest of Europe
11.1.7.6.1 Overview
11.1.7.6.2 Rest of Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.7.6.3 Rest of Europe Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.1.7.6.4 Rest of Europe Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.1.7.6.4.1 Rest of Europe Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.1.7.6.5 Rest of Europe Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.1.7.6.6 Rest of Europe Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
11.2 United States
11.2.1 Overview
11.2.2 US Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
11.2.3 US Surrogacy Market, by Type, 2020–2030 (US$ Million)
11.2.4 US Surrogacy Market, by Technology, 2020–2030 (US$ Million)
11.2.4.1 US Surrogacy Market, for IVF by Technology, 2020–2030 (US$ Million)
11.2.5 US Surrogacy Market, by Age Group, 2020–2030 (US$ Million)
11.2.6 US Surrogacy Market, by Service Order, 2020–2030 (US$ Million)
12. Impact Of COVID-19 Pandemic on U.S. and Europe Surrogacy Market
12.1 U.S.: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
13. USA & Europe Surrogacy Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in USA & Europe Surrogacy Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 London Women's Clinic Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 The Centre for Reproductive and Genetic Health Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Miracle Baby Surrogacy
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Lotus Surrogacy
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 VittoriaVita LLC
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sensible Surrogacy
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 New Life Ukraine
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Redia Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Circle Surrogacy LLC
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Ovation Fertility
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Cost Analysis
Table 2. Europe Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. Europe Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 5. Europe Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 6. Europe Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 7. Italy Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 8. Italy Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 9. Italy Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 10. Italy Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 11. Italy Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. UK Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 14. UK Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. UK Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 16. UK Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 17. Denmark Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Denmark Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Denmark Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 20. Denmark Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 21. Denmark Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 22. The Netherlands Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 23. The Netherlands Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 24. The Netherlands Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. The Netherlands Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 26. The Netherlands Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 27. Ireland Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 28. Ireland Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 29. Ireland Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 30. Ireland Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 31. Ireland Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 36. Rest of Europe Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 37. US Surrogacy Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 38. US Surrogacy Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 39. US Surrogacy Market, for IVF by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 40. US Surrogacy Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 41. US Surrogacy Market, by Service Order – Revenue and Forecast to 2030 (US$ Million)
Table 42. Organic Developments in the USA & Europe Surrogacy Market
Table 43. Inorganic Developments in the USA & Europe Surrogacy Market
Table 44. Glossary of Terms
LIST OF FIGURES
Figure 1. US and Europe Surrogacy market Segmentation
Figure 2. US and Europe Surrogacy market Segmentation, by Country
Figure 3. US and Europe Surrogacy market Overview
Figure 4. Gestation Largest Share of Type Segment in US and Europe Surrogacy Market
Figure 5. Europe Expected to Show Remarkable Growth During Forecast Period
Figure 6. US and Europe Surrogacy market – Leading Country Markets (US$ Million)
Figure 7. US and Europe Surrogacy Market, Industry Landscape
Figure 8. US PEST Analysis
Figure 9. Europe PEST Analysis
Figure 10. Surrogacy Market: Impact Analysis of Drivers and Restraints
Figure 11. US and Europe Surrogacy market – Revenue Forecast and Analysis – 2020–2030
Figure 12. US and Europe Surrogacy Market, by Type, 2022 & 2030 (%)
Figure 13. Gestational Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Traditional Surrogacy: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. US and Europe Surrogacy Market, by Type, 2022 & 2030 (%)
Figure 16. Intrauterine Insemination (IUI): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. In-Vitro Fertilization (IVF): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Classical/Standard IVF: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Intracytoplasmic Sperm Injection (ICSI): US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. US and Europe Surrogacy Market, by Age Group, 2022 & 2030 (%)
Figure 21. Below 35 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22.-37 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.-39 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24.-42 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25.-44 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Over 44 Years: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. US and Europe Surrogacy Market, by Service Order, 2022 & 2030 (%)
Figure 28. Hospitals: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Fertility Clinics: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: US and Europe Surrogacy Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Europe Surrogacy Market Revenue Overview, by Country, 2022 (US$ Mn)
Figure 32. Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 33. Europe Surrogacy Market, by Country, 2022 & 2030 (%)
Figure 34. Italy Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 35. UK Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 36. Denmark Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 37. The Netherlands Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 38. Ireland Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 39. Rest of Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 40. US Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 41. Impact of COVID-19 Pandemic in United States Markets
Figure 42. Impact of COVID-19 Pandemic in European Country Markets
Figure 43. Growth Strategies in USA & Europe Surrogacy Market (%)
The List of Companies - US and Europe Surrogacy Market
- London Women's Clinic Ltd
- The Centre for Reproductive and Genetic Health Ltd
- Miracle Baby Surrogacy
- Lotus Surrogacy
- VittoriaVita LLC
- Sensible Surrogacy
- New Life Ukraine
- Redia Ltd
- Circle Surrogacy LLC
- Ovation Fertility
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For